Rabbit Recombinant Monoclonal HIF-1 alpha antibody. Suitable for IP, ChIC/CUT&RUN-seq, ChIP-seq, WB, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 195 publications.
IgG
Rabbit
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Liquid
Monoclonal
IP | ChIC/CUT&RUN-seq | ChIP-seq | WB | ICC/IF | |
---|---|---|---|---|---|
Human | Tested | Tested | Tested | Tested | Tested |
Mouse | Expected | Expected | Expected | Tested | Expected |
Rat | Expected | Expected | Expected | Tested | Expected |
Cow | Predicted | Predicted | Predicted | Predicted | Predicted |
Ferret | Predicted | Predicted | Predicted | Predicted | Predicted |
Primates | Predicted | Predicted | Predicted | Predicted | Predicted |
Rabbit | Predicted | Predicted | Predicted | Predicted | Predicted |
Sheep | Predicted | Predicted | Predicted | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/30 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Sheep, Rabbit, Cow, Ferret, Primates | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 5 µg | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Sheep, Rabbit, Cow, Ferret, Primates | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 8 µg for 107 Cells | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Sheep, Rabbit, Cow, Ferret, Primates | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/1000 | Notes HIF-1 alpha expression is absent in most normal tissues (PMID: 12128120, 24835245, 11689469, 20217131). The antibody only works in hypoxic cell and tissue lysates. |
Species Rat | Dilution info 1/1000 | Notes HIF-1 alpha expression is absent in most normal tissues (PMID: 12128120, 24835245, 11689469, 20217131). The antibody only works in hypoxic cell and tissue lysates. |
Species Human | Dilution info 1/1000 | Notes HIF-1 alpha expression is absent in most normal tissues (PMID: 12128120, 24835245, 11689469, 20217131). The antibody only works in hypoxic cell and tissue lysates. |
Species | Dilution info | Notes |
---|---|---|
Species Sheep, Rabbit, Cow, Ferret, Primates | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Sheep, Rabbit, Cow, Ferret, Primates | Dilution info - | Notes - |
Select an associated product type
Functions as a master transcriptional regulator of the adaptive response to hypoxia (PubMed:11292861, PubMed:11566883, PubMed:15465032, PubMed:16973622, PubMed:17610843, PubMed:18658046, PubMed:20624928, PubMed:22009797, PubMed:9887100, PubMed:30125331). Under hypoxic conditions, activates the transcription of over 40 genes, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia (PubMed:11292861, PubMed:11566883, PubMed:15465032, PubMed:16973622, PubMed:17610843, PubMed:20624928, PubMed:22009797, PubMed:9887100, PubMed:30125331). Plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease (PubMed:22009797). Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Activation requires recruitment of transcriptional coactivators such as CREBBP and EP300 (PubMed:9887100, PubMed:16543236). Activity is enhanced by interaction with NCOA1 and/or NCOA2 (PubMed:10594042). Interaction with redox regulatory protein APEX1 seems to activate CTAD and potentiates activation by NCOA1 and CREBBP (PubMed:10202154, PubMed:10594042). Involved in the axonal distribution and transport of mitochondria in neurons during hypoxia (PubMed:19528298).(Microbial infection) Upon infection by human coronavirus SARS-CoV-2, is required for induction of glycolysis in monocytes and the consequent proinflammatory state (PubMed:32697943). In monocytes, induces expression of ACE2 and cytokines such as IL1B, TNF, IL6, and interferons (PubMed:32697943). Promotes human coronavirus SARS-CoV-2 replication and monocyte inflammatory response (PubMed:32697943).
Hypoxia-inducible factor 1-alpha, HIF-1-alpha, HIF1-alpha, ARNT-interacting protein, Basic-helix-loop-helix-PAS protein MOP1, Class E basic helix-loop-helix protein 78, Member of PAS protein 1, PAS domain-containing protein 8, bHLHe78, HIF1A, BHLHE78, MOP1, PASD8
Rabbit Recombinant Monoclonal HIF-1 alpha antibody. Suitable for IP, ChIC/CUT&RUN-seq, ChIP-seq, WB, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 195 publications.
Hypoxia-inducible factor 1-alpha, HIF-1-alpha, HIF1-alpha, ARNT-interacting protein, Basic-helix-loop-helix-PAS protein MOP1, Class E basic helix-loop-helix protein 78, Member of PAS protein 1, PAS domain-containing protein 8, bHLHe78, HIF1A, BHLHE78, MOP1, PASD8
IgG
Rabbit
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Liquid
Monoclonal
EPR16897
Affinity purification Protein A
HIF-1 alpha expression is absent in most normal tissues (PMID: 12128120, 24835245, 11689469, 20217131). The antibody only works in hypoxic cell and tissue lysates.
Blue Ice
1-2 weeks
+4°C
-20°C
Upon delivery aliquot
Avoid freeze / thaw cycle
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Lanes 1 - 6: Merged signal (red and green). Green - ab179483 observed at 105 kDa. Red - loading control, Anti-Histone H3 antibody [mAbcam 24834] - Nuclear Loading Control and ChIP Grade ab24834, observed at 50 kDa.
ab179483 was shown to specifically react with HIF-1 alpha in wild-type HAP1 treated DMOG (0.5mM 18hr) cells as signal was lost in HAP1 knockout treated DMOG (0.5 mM 18hr) knockout cells. Wild-type and HAP1 knockout samples were subjected to SDS-PAGE. ab179483 and Anti-Histone H3 antibody [mAbcam 24834] - Nuclear Loading Control and ChIP Grade ab24834 (Mouse anti-Histone H3 loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-HIF-1 alpha antibody [EPR16897] (ab179483) at 1/1000 dilution
Lane 1: Wild-type HAP1 whole cell lysate at 40 µg
Lane 2: Wild type HAP1 treated with DMOG (0.5mM 18hr) whole cell lysate at 40 µg
Lane 3: HIF1A knockout HAP1 whole cell lysate at 40 µg
Lane 4: HIF1A knockout HAP1 treated with DMOG (0.5mM 18hr) whole cell lysate at 40 µg
Lane 5: HeLa whole cell lysate at 40 µg
Lane 6: HeLa treated with DMOG (0.5mM 18hr) whole cell lysate at 40 µg
Predicted band size: 92 kDa
Observed band size: 105 kDa
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling HIF-1-alpha with ab179483 at 1/500 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing nuclear staining in HeLa cells treated with DFO (1 mM, 24 h). The nuclear counter stain is DAPI (blue). Tubulin is detected with Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 (anti-alpha Tubulin mouse mAb) (Alexa Fluor® 594) at 1/200 dilution (red).
Blocking and diluting buffer: 5% NFDM/TBST.
The expression of HIF-1 alpha is induced by CoCl2 and maintained by MG-132 (PMID: 15836611).
All lanes: Western blot - Anti-HIF-1 alpha antibody [EPR16897] (ab179483) at 0.163 µg/mL
Lane 1: Untreated C6 (rat glial tumor glial cell), whole cell lysate at 10 µg
Lane 2: C6 treated with 400 μM CoCl2 and 20 µM MG-132 (MG-132, proteasome inhibitor ab141003) for 4 hours at 10 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 92 kDa
Observed band size: 110 kDa
Exposure time: 26s
Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of Anti-HIF-1 alpha antibody [EPR16897-145] ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab179483).
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Lysates were freshly made and used immediately to minimise protein degradation.
Lanes 1 - 4: Western blot - Anti-HIF-1 alpha antibody [EPR16897] (ab179483) at 1/1000 dilution
Lanes 1 - 4: Western blot - Anti-HIF-1 alpha antibody [EPR16897] - BSA and Azide free (Anti-HIF-1 alpha antibody [EPR16897] - BSA and Azide free ab221610)
Lane 1: Untreated HT-1080 (human fibrosarcoma epithelial cell) whole cell lysate at 20 µg
Lane 2: HT-1080 treated with 0.5 mM DFO for 24 hours whole cell lysate at 20 µg
Lane 3: HT-1080 treated with 0.5 mM DFO for 24 hours, then added 10uM MG-132 for 4 hours, whole cell lysate at 20 µg
Lane 4: HT-1080 treated with 10uM MG-132 for 4 hours, whole cell lysate at 20 µg
Observed band size: 50-110 kDa
Exposure time: 10s
Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of Anti-HIF-1 alpha antibody [EPR16897-145] ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.
HIF-1-alpha is constantly synthesized but rapidly degraded under normoxic conditions, whereas reduced oxygen concentration results in stabilization of HIF-1-alpha. (PMID: 15104534)
Exposure time: Lanes 1-4:10 seconds, Lanes 5-6: 20 seconds
All lanes: Western blot - Anti-HIF-1 alpha antibody [EPR16897] (ab179483) at 1/1000 dilution
Lanes 1 and 3: Untreated HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2: HeLa treated with 0.5mM CoCl2 for 6h whole cell lysate at 20 µg
Lane 4: HeLa treated with 0.5mM DFO for 24h whole cell lysate at 20 µg
Lane 5: Untreated NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 6: NIH/3T3 (Mouse embryonic fibroblast) treated with 0.1mM CoCl2 for 48h whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 50-110 kDa
ab179483 at 1/30 dilution immunoprecipitating HIF-1 alpha in HeLa (human cervix adenocarcinoma epithelial cell) treated with 500 µM CoCl2 for 24 hours whole cell lysate. Western blot was performed from the immunoprecipitate using ab179483 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366), was used for detection at 1/5000 dilution.
Lane 1: HeLa (human cervix adenocarcinoma epithelial cell) treated with 500 µM CoCl2 for 24 hours whole cell lysate 10 µg
Lane 2: ab179483 IP in HeLa (human cervix adenocarcinoma epithelial cell) treated with 500 µM CoCl2 for 24 hours whole cell lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab179483 in HeLa treated with 500 µM CoCl2 for 24 hours whole cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST.
Exposure time: 8 seconds.
Lane 2: Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897] (ab179483) at 1/30 dilution
Lane 2: Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897] - BSA and Azide free (Anti-HIF-1 alpha antibody [EPR16897] - BSA and Azide free ab221610)
All lanes: HeLa (human cervix adenocarcinoma epithelial cell) treated with 500 µM CoCl2 for 24 hours whole cell lysate at 10 µg
All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/5000 dilution
Observed band size: 110 kDa
Exposure time: 8s
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 HeLa (Human cervix adenocarcinoma epithelial cell line) cells treated with Cocl2 (500 μM 20h+4h) and MG-132 (10µM 4h) and 5 µg of ab179483 [EPR16897]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730 is also shown.
Additional screenshots of mapped reads can be found in the Protocol booklet in the Support and downloads section.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of Anti-HIF-1 alpha antibody [EPR16897-145] ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com